Search
-
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
(Thérapie, 2021-04-02)Article de revue -
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study
(The Lancet Regional Health - Europe. vol. 17, 2022-06)Article de revueOpen access -
Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to Vaccines
(Drug Safety. vol. 43, n° 11, pp. 1089-1104, 2020)Article de revueOpen access -
Mésusage des médicaments : caractérisation et évaluation. Cas des benzodiazépines et opiacés faibles.
(Bordeaux, 2022-03-24)Thèses de doctorat -
Medicine misuse: A systematic review and proposed hierarchical terminology
(British Journal of Clinical Pharmacology, 2020-12-08)Article de revue -
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueOpen access -
Risk of bradyarrhythmia related to ticagrelor: a systematic review and meta-analysis
(Pharmacological Research. pp. 105089, 2020)Article de revue -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueOpen access -
Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
(Frontiers in Pharmacology. vol. 12, pp. 769315, 2021-10-28)Article de revueOpen access -
Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis
(Cancers. vol. 14, n° 21, 2022-10-28)Article de revueOpen access